BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• 

  Autoimmune disease

  Immunovant Will Drop One Myasthenia Gravis Asset, Continuing to Favor Another

  Analysts were happy with batoclimab’s performance in the chronic autoimmune disorder, but Immunovant said it will continue to focus on another next-gen asset for the indication.

  March 19, 2025

   · 

  1 min read

   · 

  Annalee Armstrong
• 

  Policy

  Trump Eyes Steep Cuts to CDC HIV Prevention Program

  The CDC budget cuts could pose headwinds for HIV drugmakers like Gilead and Merck but are unlikely to severely cripple their HIV divisions, according to analysts.

  March 19, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  ZyVersa Therapeutics Highlights Data Published in the Journal of the American Heart Association Demonstrating Inflammasome Inhibition Attenuates Obesity-Associated Cardiomyopathy in Animal Model Study

  March 19, 2025

   · 

  6 min read
• Press Releases

  SIGA Appoints Retired General John M. Keane to its Board of Directors

  March 19, 2025

   · 

  7 min read
• Press Releases

  MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress

  March 19, 2025

   · 

  7 min read
• Press Releases

  Protagonist Therapeutics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2025

  March 19, 2025

   · 

  6 min read
• Press Releases

  Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular Edema

  March 19, 2025

   · 

  5 min read
• Press Releases

  Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

  March 19, 2025

   · 

  1 min read
• Press Releases

  Hoth Therapeutics Announces Positive Preclinical Results for HT-KIT in Aggressive Cancer Gastrointestinal Stromal Tumors (GIST). HT-KIT Triggered Significant Tumor Cell Death as Early as 24 Hours Post-treatment

  March 19, 2025

   · 

  6 min read
• Press Releases

  Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition

  March 19, 2025

   · 

  6 min read